Kazia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.About KZIA
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer.
CEOJohn E. Friend
CEOJohn E. Friend
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1994
Founded1994
Employees—
Employees—
KZIA Key Statistics
Market cap108.10M
Market cap108.10M
Price-Earnings ratio-1.41
Price-Earnings ratio-1.41
Dividend yield—
Dividend yield—
Average volume338.05K
Average volume338.05K
High today$10.79
High today$10.79
Low today$9.23
Low today$9.23
Open price$10.79
Open price$10.79
Volume531.02K
Volume531.02K
52 Week high$17.40
52 Week high$17.40
52 Week low$4.86
52 Week low$4.86
KZIA News
TipRanks 2d
Kazia Therapeutics Gains $2 Million Milestone as Sovargen Doses First Paxalisib Patient in Rare Epilepsy TrialKazia Therapeutics ( (KZIA) ) has issued an update. On September 22, 2026, Kazia Therapeutics reported that Korea-based Sovargen Co., which holds exclusive glo...
TipRanks 6d
Kazia Therapeutics Switches ADR Depositary to JPMorgan as ADSs Remain on NasdaqAn update from Kazia Therapeutics ( (KZIA) ) is now available. On September 18, 2026, Kazia Therapeutics Limited announced it has appointed JPMorgan Chase Bank...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.